{"id":2953,"date":"2025-08-23T18:12:56","date_gmt":"2025-08-23T18:12:56","guid":{"rendered":"https:\/\/newsletter.pharmevo.biz\/?p=2953"},"modified":"2025-08-23T18:12:57","modified_gmt":"2025-08-23T18:12:57","slug":"l-e-a-p-learn-engage-apply-perform","status":"publish","type":"post","link":"https:\/\/newsletter.pharmevo.biz\/vol6-jul24-dec24\/l-e-a-p-learn-engage-apply-perform\/","title":{"rendered":"L.E.A.P (Learn. Engage. Apply. Perform)"},"content":{"rendered":"\n

PharmEvo has nurtured a culture of learning and innovation over several years that has become one of our competitive advantages in the industry.<\/p>\n\n\n\n

To take the legacy ahead, top Leadership embarked on the journey of Franklin Covey All Access Pass leadership development courses in FY 2023-24. As the courses were backed by research-based content and useful practical frameworks, the Learning & Development (L&D) department has decided to cascade the learning<\/strong> from selected courses to each and every member of Evodian family in FY 2024-25.<\/strong><\/p>\n\n\n\n

Consequently,  the L&D department announced L.E.A.P (Learn. Engage. Apply. Perform), <\/strong>an organization-wide massive intellectual project through which top Leadership conducted the trainings for Evodians. The first course<\/strong> for this program was Multipliers by Liz Wisemen<\/strong>.<\/p>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n<\/figure>\n","protected":false},"excerpt":{"rendered":"

PharmEvo has nurtured a culture of learning and innovation over several years that has become one of our competitive advantages in the industry. To take the legacy ahead, top Leadership embarked on the journey of Franklin Covey All Access Pass leadership development courses in FY 2023-24. As the courses were backed by research-based content and […]<\/p>\n","protected":false},"author":1,"featured_media":2742,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[61],"tags":[],"class_list":["post-2953","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-leap"],"_links":{"self":[{"href":"https:\/\/newsletter.pharmevo.biz\/vol6-jul24-dec24\/wp-json\/wp\/v2\/posts\/2953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newsletter.pharmevo.biz\/vol6-jul24-dec24\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/newsletter.pharmevo.biz\/vol6-jul24-dec24\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/newsletter.pharmevo.biz\/vol6-jul24-dec24\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/newsletter.pharmevo.biz\/vol6-jul24-dec24\/wp-json\/wp\/v2\/comments?post=2953"}],"version-history":[{"count":1,"href":"https:\/\/newsletter.pharmevo.biz\/vol6-jul24-dec24\/wp-json\/wp\/v2\/posts\/2953\/revisions"}],"predecessor-version":[{"id":2957,"href":"https:\/\/newsletter.pharmevo.biz\/vol6-jul24-dec24\/wp-json\/wp\/v2\/posts\/2953\/revisions\/2957"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/newsletter.pharmevo.biz\/vol6-jul24-dec24\/wp-json\/wp\/v2\/media\/2742"}],"wp:attachment":[{"href":"https:\/\/newsletter.pharmevo.biz\/vol6-jul24-dec24\/wp-json\/wp\/v2\/media?parent=2953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/newsletter.pharmevo.biz\/vol6-jul24-dec24\/wp-json\/wp\/v2\/categories?post=2953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/newsletter.pharmevo.biz\/vol6-jul24-dec24\/wp-json\/wp\/v2\/tags?post=2953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}